Biofrontera AG Logo

Biofrontera AG

Biopharmaceutical firm specializing in photodynamic therapy for skin conditions.

B8F | F

Overview

Corporate Details

ISIN(s):
DE000A409625 (+2 more)
LEI:
391200D6GFSVFGFQTL13
Country:
Germany
Address:
Hemmelrather Weg 201, 51377 Leverkusen

Description

Biofrontera AG is a biopharmaceutical company that specializes in dermatology. The company develops and markets innovative products for the treatment, care, and protection of the skin. Its core expertise is in photodynamic therapy (PDT), a non-invasive treatment for various skin conditions. Biofrontera's products are primarily focused on treating forms of non-melanoma skin cancer, such as actinic keratosis, field cancerization, and basal cell carcinoma. The portfolio includes both dermatological drugs and medical cosmetics.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2016-03-18 00:00
Datum:18.03.2016
German 12.3 KB
2015-11-12 00:00
Datum:12.11.2015
German 13.2 KB
2015-08-03 00:00
Datum:03.08.2015
German 13.2 KB
2015-05-11 00:00
Datum:11.05.2015
German 12.1 KB
2015-05-08 00:00
Datum:08.05.2015
German 599.9 KB
2014-10-27 00:00
Datum:27.10.2014
German 12.1 KB
2014-07-14 00:00
Datum:14.07.2014
German 12.1 KB
2014-05-07 00:00
Datum:07.05.2014
German 13.0 KB
2014-04-01 00:00
Datum:01.04.2014
German 568.9 KB
2014-03-31 00:00
Datum:31.03.2014
German 260.3 KB
2014-03-10 00:00
Datum:10.03.2014
German 13.0 KB
2013-11-12 00:00
Datum:12.11.2013
German 30.1 KB
2013-08-02 00:00
Datum:02.08.2013
German 227.2 KB
2013-07-22 00:00
Datum:22.07.2013
German 13.0 KB
2013-05-15 00:00
Datum:15.05.2013
German 13.0 KB

Automate Your Workflow. Get a real-time feed of all Biofrontera AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Biofrontera AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Biofrontera AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-03-24 Deutsche Balaton Aktiengesellschaft Close relation Buy None 7,366.00 EUR
2023-03-24 Deutsche Balaton Aktiengesellschaft Close relation Buy None 381.00 EUR
2023-03-20 Deutsche Balaton Aktiengesellschaft Close relation Buy None 7,503.16 EUR
2023-03-13 NEON Equity AG Close relation Buy None 30,627.00 EUR
2023-03-13 Deutsche Balaton Aktiengesellschaft Close relation Buy None 6,290.31 EUR
2023-03-13 Deutsche Balaton Aktiengesellschaft Close relation Buy None 635.00 EUR
2023-03-13 TO Holding 1 GmbH Close relation Buy None 575.00 EUR
2023-03-10 Deutsche Balaton Aktiengesellschaft Close relation Buy None 6,718.30 EUR
2023-03-08 Adenauer, Dr. Sven-Georg Other Buy None 140,000.00 EUR
2023-03-06 Deutsche Balaton Aktiengesellschaft Close relation Buy None 152.40 EUR

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.